MetLife Investment Advisors LLC Lowers Position in Surgery Partners Inc (SGRY)

MetLife Investment Advisors LLC lessened its position in Surgery Partners Inc (NASDAQ:SGRY) by 35.6% during the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 9,540 shares of the company’s stock after selling 5,267 shares during the period. MetLife Investment Advisors LLC’s holdings in Surgery Partners were worth $93,000 as of its most recent filing with the SEC.

Several other large investors have also recently modified their holdings of SGRY. Zurcher Kantonalbank Zurich Cantonalbank acquired a new stake in shares of Surgery Partners in the 4th quarter valued at $54,000. Menta Capital LLC acquired a new stake in shares of Surgery Partners in the 4th quarter valued at $99,000. Principal Financial Group Inc. boosted its stake in shares of Surgery Partners by 9.5% in the 4th quarter. Principal Financial Group Inc. now owns 19,325 shares of the company’s stock valued at $189,000 after purchasing an additional 1,672 shares in the last quarter. Barclays PLC boosted its stake in shares of Surgery Partners by 84.7% in the 4th quarter. Barclays PLC now owns 23,145 shares of the company’s stock valued at $226,000 after purchasing an additional 10,615 shares in the last quarter. Finally, Rhumbline Advisers boosted its stake in shares of Surgery Partners by 42.1% in the 4th quarter. Rhumbline Advisers now owns 26,687 shares of the company’s stock valued at $261,000 after purchasing an additional 7,900 shares in the last quarter. Institutional investors own 96.33% of the company’s stock.

Several equities research analysts have recently commented on SGRY shares. Stifel Nicolaus set a $12.00 target price on shares of Surgery Partners and gave the company a “hold” rating in a research note on Wednesday, May 8th. BidaskClub upgraded shares of Surgery Partners from a “hold” rating to a “buy” rating in a research report on Thursday, February 7th. ValuEngine downgraded shares of Surgery Partners from a “buy” rating to a “hold” rating in a research report on Thursday, February 7th. Finally, Zacks Investment Research upgraded shares of Surgery Partners from a “strong sell” rating to a “hold” rating in a research report on Wednesday, April 24th. One research analyst has rated the stock with a sell rating, four have issued a hold rating and three have issued a buy rating to the stock. Surgery Partners presently has an average rating of “Hold” and an average target price of $17.60.

In other Surgery Partners news, Director Adam T. Feinstein sold 7,865 shares of the business’s stock in a transaction dated Monday, May 20th. The stock was sold at an average price of $9.95, for a total transaction of $78,256.75. Following the completion of the sale, the director now directly owns 8,895 shares of the company’s stock, valued at approximately $88,505.25. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 8.20% of the company’s stock.

NASDAQ SGRY traded down $0.05 on Wednesday, hitting $10.23. 418,308 shares of the company were exchanged, compared to its average volume of 250,128. The company has a market cap of $498.73 million, a price-to-earnings ratio of -4.18 and a beta of 2.47. The company has a quick ratio of 1.56, a current ratio of 1.49 and a debt-to-equity ratio of 2.20. Surgery Partners Inc has a 1-year low of $9.14 and a 1-year high of $18.70.

Surgery Partners (NASDAQ:SGRY) last issued its quarterly earnings results on Wednesday, May 8th. The company reported ($0.42) earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.39) by ($0.03). The company had revenue of $416.80 million for the quarter, compared to analyst estimates of $421.41 million. Surgery Partners had a negative return on equity of 4.01% and a negative net margin of 11.59%. The firm’s quarterly revenue was up 1.3% on a year-over-year basis. During the same quarter last year, the company earned ($0.26) EPS. On average, equities analysts expect that Surgery Partners Inc will post -0.59 earnings per share for the current year.

COPYRIGHT VIOLATION NOTICE: This report was posted by Sundance Herald and is the property of of Sundance Herald. If you are reading this report on another publication, it was illegally stolen and republished in violation of US and international trademark & copyright law. The original version of this report can be accessed at https://sundanceherald.com/2019/05/22/metlife-investment-advisors-llc-has-93000-holdings-in-surgery-partners-inc-sgry.html.

Surgery Partners Company Profile

Surgery Partners, Inc, through its subsidiaries, owns and operates a network of surgical facilities and related services in the United States. The company operates through three segments: Surgical Facility Services, Ancillary Services, and Optical Services. Its surgical facilities comprise ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including gastroenterology, general surgery, ophthalmology, orthopedics, and pain management.

Recommended Story: Day Trading – Risk Worth the Reward?

Institutional Ownership by Quarter for Surgery Partners (NASDAQ:SGRY)

Receive News & Ratings for Surgery Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Surgery Partners and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply